| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/28/2002 | WO2002016365A1 Pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting erab or hadh2 activity |
| 02/28/2002 | WO2002016333A2 Thioflavin derivatives and their use in diagnosis and theraphy of alzheimer's disease |
| 02/28/2002 | WO2002016310A1 Selective androgen receptor modulators and methods of use thereof |
| 02/28/2002 | WO2002016043A1 Centrifugal separator and analyzer with the separator |
| 02/28/2002 | WO2002015942A1 Method for the identification of agents that inhibit or promote cataracts and uses thereof |
| 02/28/2002 | WO2002015929A1 Methods and compositions for use in the diagnosis and treatment of chronic immune disease |
| 02/28/2002 | WO2002015920A2 Treatment of hyperproliferative diseases |
| 02/28/2002 | WO2002015918A2 Method and compositions for promoting osteogenesis |
| 02/28/2002 | WO2002015895A2 Alpha-difluoromethylornithine (dfmo) use in the human prostate |
| 02/28/2002 | WO2002015800A1 Method for transdermal nucleic acid sampling |
| 02/28/2002 | WO2002015779A2 Method and apparatus for determining blood oxygen transport |
| 02/28/2002 | WO2002015777A1 Methods and devices for prediction of hypoglycemic events |
| 02/28/2002 | WO2002015722A2 Treatment of helicobacter with isothiocyanates |
| 02/28/2002 | WO2002015680A1 Type iii allergic inflammation model animal |
| 02/28/2002 | WO2002004658A8 Compositions to measure protein concentration |
| 02/28/2002 | WO2002002631A8 Structure-based drug design method to identify compounds that bind to cd81, a cell receptor for hepatitis-c |
| 02/28/2002 | WO2002002586A8 Isolated nucleic acids and polypeptides associated with glucose homeostasis disorders and method of detecting the same |
| 02/28/2002 | WO2001090749A3 Scanning kelvin microprobe system and process for biomolecule microassay |
| 02/28/2002 | WO2001090730A3 Scanning kelvin microprobe system and process for analyzing a surface |
| 02/28/2002 | WO2001087833A3 System and method for managing and analyzing carbohydrate sequences |
| 02/28/2002 | WO2001087055A3 New screening tool for analyzing the behavior of laboratory animals |
| 02/28/2002 | WO2001086248A3 Platelet function assay and reagent therefor |
| 02/28/2002 | WO2001085779A3 Protein complexes and assays for screening anti-cancer agents |
| 02/28/2002 | WO2001085762A3 Cancer diagnosis and assays for screening anti-cancer agents |
| 02/28/2002 | WO2001080722A3 Methods and compositions for the diagnosis of schizophrenia |
| 02/28/2002 | WO2001080716A3 Methods and compositions for the diagnosis of schizophrenia |
| 02/28/2002 | WO2001079216A3 Polyamide nucleic acid derivatives, agents and methods for producing them |
| 02/28/2002 | WO2001078796A9 Type ii gonadotropin-releasing hormone receptor and polynucleotides encoding therefor |
| 02/28/2002 | WO2001077377A8 Diagnosis of diseases associated with dna replication by assessing dna methylation |
| 02/28/2002 | WO2001075064A3 Method and materials relating to insulin-like growth factor binding protein-like polypeptides and polynucleotides |
| 02/28/2002 | WO2001074242A3 Capillary flow control in a medical diagnostic device |
| 02/28/2002 | WO2001074159A3 Systems and methods for collecting plasma that is free or virtually free of cellular blood species |
| 02/28/2002 | WO2001073029A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 02/28/2002 | WO2001071322A3 Method and apparatus for multiple-analyte assay |
| 02/28/2002 | WO2001071316A3 One-dimensional arrays on optical fibers |
| 02/28/2002 | WO2001070984A3 Anti-tissue factor antibodies with enhanced anticoagulant potency |
| 02/28/2002 | WO2001068908A3 T2k kinase assays |
| 02/28/2002 | WO2001065998A3 Methods for the diagnosis and treatment of breast cancer |
| 02/28/2002 | WO2001062979A3 Dentification of partial agonists of the a2a adenosine receptor |
| 02/28/2002 | WO2001062895A3 Simultaneous stimulation and concentration of cells |
| 02/28/2002 | WO2001060246A3 Multivariate analysis of green to ultraviolet spectra of cell and tissue samples |
| 02/28/2002 | WO2001055345A3 Method for producing a serum-containing culture medium for cells and the use thereof |
| 02/28/2002 | WO2001053339A3 Egg specific surface proteins |
| 02/28/2002 | WO2001042474A3 Interferon-like molecules and uses thereof |
| 02/28/2002 | WO2001042462A3 Phospholipase a2 inhibitory peptides from python reticulatus |
| 02/28/2002 | WO2001040266A3 Insect poison allergens with reduced ige reactivity and method for producing the same |
| 02/28/2002 | WO2001038879A3 Method, apparatus, media and signals for identifying associated cell signaling proteins |
| 02/28/2002 | WO2001032702A3 Molecular structure of rhd negative locus |
| 02/28/2002 | WO2001031029A3 Human sphingosine kinase gene |
| 02/28/2002 | WO2001027261A3 Conjugates between a peptides and a nucleic acid analog, such as a pna, lna or a morpholino |
| 02/28/2002 | WO2001023414B1 Immunologically significant herpes simplex virus antigens |
| 02/28/2002 | WO2001005422A3 Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease |
| 02/28/2002 | WO2000077037A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/28/2002 | US20020026649 Metastasis models using green fluorescent protein (GFP) as a marker |
| 02/28/2002 | US20020026648 Function-based small molecular weight compound screening system in drosophila melanogaster |
| 02/28/2002 | US20020026288 Chip, genomic drug prescription support system, chip information offering system, chip supply system,and computer storage medium |
| 02/28/2002 | US20020026108 Optical-based sensing devices |
| 02/28/2002 | US20020026044 For treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, psoriasis; for wound healing |
| 02/28/2002 | US20020026040 And isolated nucleic acids containing coding regions of genes encoding such proteins; for use in gene therapy treatment of cancer, autoimmune diseases, viral diseases |
| 02/28/2002 | US20020026024 Isobutene polymerisation process |
| 02/28/2002 | US20020025956 Nervous system, psychological disorders |
| 02/28/2002 | US20020025584 Method of determining cholesterol and sensor applicable to the same |
| 02/28/2002 | US20020025575 Device for the meeasurement of membrane conductance; for use in monitoring propagation and metabolic activity |
| 02/28/2002 | US20020025574 Device for detection of preferential particles in solution; for use in detection of allergies |
| 02/28/2002 | US20020025573 Multi-well plate and electrode assemblies for ion channel assays |
| 02/28/2002 | US20020025569 Enzymatic polypeptide; for use as a tool in the diagnosis of abberant protein degradation, cell differentiation and proliferation |
| 02/28/2002 | US20020025568 Classifying activity of membrane protein modulators; obtain cells, expose to modulators, pulse cells with electricity, detecting fluorescence emission from cells |
| 02/28/2002 | US20020025559 Nucleotide sequences for use in the diagnosis and treatment of hypertension, heart, and kidney defects |
| 02/28/2002 | US20020025558 Human MAD proteins and uses thereof |
| 02/28/2002 | US20020025551 Novel molecules of the t129-related protein family and uses thereof |
| 02/28/2002 | US20020025547 Bioreactor and bioprocessing technique |
| 02/28/2002 | US20020025546 Using tetrazolium compound |
| 02/28/2002 | US20020025544 Detection of hypertension using immunoreactive metabolic products |
| 02/28/2002 | US20020025543 Methods and kits for diagnosing tumorigenicity and determining resistance to the antineoplastic effects of antiestrogen therapy |
| 02/28/2002 | US20020025542 Antigen cocktails and uses thereof |
| 02/28/2002 | US20020025541 Apparatus for use in detection of hormones, metabolites, poisons and antigens |
| 02/28/2002 | US20020025540 Isolation of functionally active gamma- secretase protein complex and methods for detection of activity and Inhibitors thereof |
| 02/28/2002 | US20020025538 Medical kit |
| 02/28/2002 | US20020025537 High-throughput methods for generating and screening compounds that affect cell viability |
| 02/28/2002 | US20020025535 Evaluating libraries of preferential particle; bind ligands with targets, monitor adjustment in core positioning, form clusters according positional adjustments |
| 02/28/2002 | US20020025534 Method and apparatus for assay for multiple analytes |
| 02/28/2002 | US20020025533 Monitoring sample for the presence of preferential particles; provide apparatus, insert sample, generate alternating fluid flow, monitor and detect signal |
| 02/28/2002 | US20020025530 PCR-based multiplex assay for determining haplotype |
| 02/28/2002 | US20020025521 Pin1 as a marker for abnormal cell growth |
| 02/28/2002 | US20020025516 Nrde |
| 02/28/2002 | US20020025515 Inviable virus particles as scaffolds for constructing flexible detection systems |
| 02/28/2002 | US20020025513 Antigen/antibody specificity exchanger |
| 02/28/2002 | US20020025512 Fluorescence polarization- based diagnostic assay for equine infectious anemia virus |
| 02/28/2002 | US20020025509 System and method for optimizing tissue barrier transfer of compounds |
| 02/28/2002 | US20020025347 Administering a metabolite of a Salviae Miltiorrhizae Radix herb to the diabetic individual for therapy of diabetic nephropathy |
| 02/28/2002 | US20020025328 As vaccines for immunization |
| 02/28/2002 | US20020025317 For therapy and prophylaxis of pathological condition associated with expression of Interelukin-12 and/or Interleukin-18, including excessive or inappropriate amounts of those cytokines |
| 02/28/2002 | US20020025305 Cell-cycle regulatory proteins, and uses related thereto |
| 02/28/2002 | US20020025297 Methods of screening agents for activity using teleosts |
| 02/28/2002 | US20020025276 Apparatus for treating objects |
| 02/28/2002 | US20020025275 For performing a biochemical inspection or an immunity inspection |
| 02/28/2002 | US20020025061 High speed and reliable determination of lumber quality using grain influenced distortion effects |
| 02/28/2002 | US20020024346 Method of inspecting piezoelectric ceramic device |
| 02/28/2002 | US20020024026 System, method, and computer software product for specifying a scanning area of a substrate |
| 02/28/2002 | US20020023892 Ball and socket closure |